Product correctly added to cart.

discount label
6-Bromoquinoxaline
View 3D

Biosynth logo

6-Bromoquinoxaline

CAS: 50998-17-9

Ref. 3D-FB140222

2gTo inquire
5gTo inquire
10gTo inquire
25gTo inquire
50gTo inquire
Estimated delivery in United States, on Wednesday 22 Jan 2025

Product Information

Name:
6-Bromoquinoxaline
Synonyms:
  • Quinoxaline, 6-bromo-
Description:

6-Bromoquinoxaline is a small molecule that inhibits the activity of cyclin-dependent kinases (CDKs) 4 and 6. CDKs are enzymes that regulate the progression of cells through the cell cycle, which is important for cancer prevention. 6-Bromoquinoxaline has been shown to be a potent inhibitor of PD-L1 and pd-L1 expression in vitro and in vivo. This drug is also an antibacterial agent with pharmacophore properties that inhibit bacterial growth by binding to membrane cytochrome c oxidase and catalysing its oxidation. 6-Bromoquinoxaline binds to the type 1 receptor on T cells, leading to death ligand-induced apoptosis.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
209.04 g/mol
Formula:
C8H5BrN2
Purity:
Min. 95%
InChI:
InChI=1S/C8H5BrN2/c9-6-1-2-7-8(5-6)11-4-3-10-7/h1-5H
InChI key:
InChIKey=NOYFLUFQGFNMRB-UHFFFAOYSA-N
SMILES:
Brc1ccc2nccnc2c1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FB140222 6-Bromoquinoxaline

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".